NTRK
NTRK gene fusions occur rarely across cancer types. Tumor-agnostic indication for larotrectinib and entrectinib.
No Clinical Trials found for this biomarker.
NTRK gene fusions occur rarely across cancer types. Tumor-agnostic indication for larotrectinib and entrectinib.
No Clinical Trials found for this biomarker.